Dubai: The Emirates Drug Authority stressed the need to obtain its approval before publishing or circulating medical advertisements and to comply with regulations governing claims and promotional practices, including the prohibition of advertising or promoting medical products through social media influencers.
The announcement came during the Medical Products Advertising Council, organised by the Foundation at the Government Accelerators Centre in Emirates Towers, Dubai.
The council brought together partners, stakeholders and industry representatives to raise awareness of the requirement to obtain approval before publishing or distributing advertisements. It also aimed to familiarise participants with the latest regulatory developments related to promotional content and strengthen compliance with applicable frameworks and requirements.
The council reviewed key updates, including regulations governing advertisements for prescription drugs and the scope of advertising media covered. These include printed, audio and visual materials, outdoor screens, websites, social media platforms and other digital channels.
Participants also discussed the process for submitting approval requests through the electronic system, including the documents and content that must be provided depending on the type of advertisement and the medium used. The stages for reviewing and completing applications were outlined, along with requirements for visual and audio content.
Discussions also covered regulations governing advertising content, including the need for information to be accurate and clear and to avoid misleading claims. Advertising material must be consistent with the approved data and uses of the product.
Relevant risks or side effects and required warnings must also be presented according to the type of product and target audience. The council also emphasised the importance of ensuring that advertising does not encourage the public to self-diagnose or use treatments without appropriate medical supervision.